1 351 115 ASSESSMENT OF SIGNIFICANCE OF YOGA ON QUALITY OF LIFE IN ASTHMA PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: ASTHMA IS A CHRONIC INFLAMMATORY RESPIRATORY DISEASE CHARACTERIZED BY PERIODIC ATTACKS OF WHEEZING, SHORTNESS OF BREATH AND A TIGHT FEELING IN THE CHEST. THE CURRENT STUDY IS BASED ON THE EFFECT OF YOGA ON QUALITY OF LIFE IN ASTHMATICS IN NORTHERN INDIA. MATERIALS AND METHODS: A TOTAL OF 300 PARTICIPANTS OF MILD-TO-MODERATE PERSISTENT ASTHMA (FEV1 >60%) AGED BETWEEN 12 AND 60 YEARS WERE RECRUITED FROM THE DEPARTMENT OF PULMONARY MEDICINE. THEIR QUALITY OF LIFE WAS ASSESSED WITH THE HELP OF MINI ASTHMA QUALITY-OF-LIFE QUESTIONNAIRE (AQLQ) AT BASELINE AND THEN AFTER 3(RD) AND 6(TH) MONTH FROM BASELINE. FORTY-FIVE PARTICIPANTS WERE DROPPED OUT DURING THE STUDY WHILE 255 PARTICIPANTS COMPLETED THE STUDY SUCCESSFULLY. RESULTS: IN "THE YOGA GROUP," SIGNIFICANT IMPROVEMENTS WERE FOUND IN ALL THE SUBDOMAINS OF AQLQ AT 3(RD) MONTH AND AT 6(TH) MONTH IN COMPARISON TO "THE CONTROL GROUP." THE NUMBER NEEDED TO TREAT WAS FOUND TO BE 2.67 FOR THE TOTAL AQLQ SCORE WHICH WAS GREATER THAN THE MINIMAL IMPORTANT DIFFERENCE. CONCLUSION: "THE YOGA GROUP" GOT SIGNIFICANTLY BETTER IMPROVEMENT IN ASTHMA QUALITY-OF-LIFE SCORES THAN "THE CONTROL GROUP." THUS, YOGA CAN BE USED AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF ASTHMA. 2017 2 1401 65 IMPACT OF YOGA ON BIOCHEMICAL PROFILE OF ASTHMATICS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: ASTHMA IS A CHRONIC INFLAMMATORY DISORDER OF THE AIRWAYS. THE CHRONIC INFLAMMATION CAUSES AN ASSOCIATED INCREASE IN AIRWAY HYPERRESPONSIVENESS THAT LEADS TO RECURRENT EPISODES OF WHEEZING, BREATHLESSNESS, CHEST TIGHTNESS, AND COUGHING AT NIGHT OR IN THE EARLY MORNING. MOST OF THE STUDIES HAVE REPORTED, AS THE EFFECTS OF YOGA ON BRONCHIAL ASTHMA, SIGNIFICANT IMPROVEMENTS IN PULMONARY FUNCTIONS, QUALITY OF LIFE, AND DECREASE IN MEDICATION USE, BUT NONE OF THE STUDIES HAS ATTEMPTED TO SHOW THE EFFECT OF YOGA ON BIOCHEMICAL CHANGES. OBJECTIVE: TO EVALUATE THE EFFECT OF YOGA ON BIOCHEMICAL PROFILE OF ASTHMATICS. MATERIALS AND METHODS: IN THE PRESENT STUDY, 276 PATIENTS OF MILD TO MODERATE ASTHMA (FEV 1> 60%) AGED BETWEEN 12 TO 60 YEARS WERE RECRUITED FROM THE DEPARTMENT OF PULMONARY MEDICINE, KING GEORGE'S MEDICAL UNIVERSITY, U.P., LUCKNOW, INDIA. THEY WERE RANDOMLY DIVIDED INTO TWO GROUPS: YOGA GROUP (WITH STANDARD MEDICAL TREATMENT AND YOGIC INTERVENTION) AND CONTROL GROUP AS STANDARD MEDICAL TREATMENT (WITHOUT YOGIC INTERVENTION). AT COMPLETION OF 6 MONTHS OF THE STUDY PERIOD, 35 SUBJECTS WERE DROPPED OUT, SO OUT OF 276 SUBJECTS, ONLY 241 SUBJECTS COMPLETED THE WHOLE STUDY (121 SUBJECTS FROM YOGA GROUP AND 120 SUBJECTS FROM CONTROL GROUP). BIOCHEMICAL ASSESSMENT WAS CARRIED OUT AT BASELINE AND AFTER 6 MONTHS OF THE STUDY PERIOD. RESULTS: IN YOGA GROUP, THERE WAS SIGNIFICANT IMPROVEMENT FOUND IN THE PROPORTION OF HEMOGLOBIN AND ANTIOXIDANT SUPEROXIDE DISMUTASE IN COMPARISON TO CONTROL GROUP AND SIGNIFICANT DECREASE WAS FOUND IN TOTAL LEUKOCYTE COUNT (TLC) AND DIFFERENTIAL LEUKOCYTES COUNT IN COMPARISON TO CONTROL GROUP. THERE WAS NO SIGNIFICANT CHANGE FOUND IN TLC, POLYMORPHS, AND MONOCYTES IN BETWEEN GROUP COMPARISON. CONCLUSIONS: YOGA GROUP GOT SIGNIFICANTLY BETTER IMPROVEMENT IN BIOCHEMICAL VARIABLES THAN CONTROL GROUP. RESULT SHOWS THAT YOGA CAN BE PRACTICED AS ADJUVANT THERAPY WITH STANDARD INHALATION THERAPY FOR BETTER OUTCOME OF ASTHMA. 2014 3 353 40 ASSESSMENT OF THE QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA, BEFORE AND AFTER YOGA: A RANDOMISED TRIAL. YOGA WHICH IS USED AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS GAINING POPULARITY THROUGHOUT THE WORLD. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFECT OF YOGA ON QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 120 NON-SMOKING MALE AND FEMALE PATIENTS OF ASTHMA IN THE AGE GROUP OF 17-50 YEARS WERE RANDOMIZED INTO TWO GROUPS I.E. GROUP A (YOGA GROUP) AND GROUP B (CONTROL GROUP). ALL PATIENTS REMAINED ON THEIR PRESCRIBED MEDICATION, BUT GROUP A PATIENTS PRACTICED YOGA BREATHING EXERCISES FOR 8 WEEKS. ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) AND DIARY RECORD WAS USED TO ASSESS QUALITY OF LIFE, NUMBER AND SEVERITY OF ASTHMATIC ATTACKS, AND THE DOSAGE OF THE MEDICATION REQUIRED AT BASELINE AND AFTER 8 WEEKS. GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN "SYMPTOMS", "ACTIVITIES" AND "ENVIRONMENTAL" DOMAINS OF AQLQ AT 8 WEEKS (P<0.01) AND SIGNIFICANT REDUCTION IN DAILY NUMBER AND SEVERITY OF ATTACKS, AND THE DOSAGE OF MEDICATION REQUIRED AT 4 AND 8 WEEKS (P<0.01) COMPARED TO THE BASELINE. YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVED QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 2014 4 214 33 A STUDY OF THE EFFECT OF YOGA TRAINING ON PULMONARY FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA. THE ROLE OF YOGA BREATHING EXERCISES, AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS WELL RECOGNIZED. ONE HUNDRED TWENTY PATIENTS OF ASTHMA WERE RANDOMIZED INTO TWO GROUPS I.E GROUP A (YOGA TRAINING GROUP) AND GROUP B (CONTROL GROUP). EACH GROUP INCLUDED SIXTY PATIENTS. PULMONARY FUNCTION TESTS WERE PERFORMED ON ALL THE PATIENTS AT BASELINE, AFTER 4 WEEKS AND THEN AFTER 8 WEEKS. MAJORITY OF THE SUBJECTS IN THE TWO GROUPS HAD MILD DISEASE (34 PATIENTS IN GROUP A AND 32 IN GROUP B). GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT INCREASING TREND (P < 0.01) IN % PREDICTED PEAK EXPIRATORY FLOW RATE (PEFR), FORCED EXPIRATORY VOLUME IN THE FIRST SECOND (FEV1), FORCED VITAL CAPACITY (FVC), FORCED MID EXPIRATORY FLOW IN 0.25-0.75 SECONDS (FEF25-75) AND FEV1/FVC% RATIO AT 4 WEEKS AND 8 WEEKS AS COMPARED TO GROUP B. THUS, YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVES PULMONARY FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA. 2009 5 2786 48 YOGA THERAPY AS AN ADJUVANT IN MANAGEMENT OF ASTHMA. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON CONTROL OF ASTHMA IN CHILDREN WITH BRONCHIAL ASTHMA. METHODS: THIS HOSPITAL-BASED INTERVENTIONAL RANDOMIZED CONTROLLED TRIAL CONDUCTED IN THE DEPARTMENT OF PEDIATRICS AT A TERTIARY CARE CENTER OF NORTH INDIA FROM NOVEMBER 2017 TO OCTOBER 2018 ENROLLED 140 NEWLY DIAGNOSED CASES OF ASTHMA OF AGE 10-16 Y WHO WERE RANDOMLY DIVIDED INTO TWO GROUPS. SEVENTY CHILDREN IN THE CASE GROUP PRACTICED YOGA UNDER SUPERVISION FOR A PERIOD OF 3 MO IN ADDITION TO PHARMACOLOGICAL TREATMENT. SEVENTY CONTROLS RECEIVED ONLY PHARMACOLOGICAL TREATMENT. PULMONARY-FUNCTION TESTS WERE DONE AT BASELINE, 6 WK, AND 12 WK ALONG WITH QUALITY OF LIFE (QOL) ASSESSMENT BY PEDIATRIC ASTHMA QUALITY OF LIFE QUESTIONNAIRE (PAQLQ). THE OUTCOME MEASURES ASSESSED WERE FORCED VITAL CAPACITY (FVC), FORCED EXPIRATORY VOLUME IN ONE SECOND (FEV1), FEV1/FVC AND PEAK EXPIRATORY FLOW RATE (PEFR). QOL EVALUATION WAS DONE IN 3 DOMAINS: ACTIVITY LIMITATION, SYMPTOMS, AND EMOTIONAL FUNCTION. RESULTS: THE ASTHMATIC CHILDREN PRACTICING YOGA HAVE SHOWN SIGNIFICANT IMPROVEMENT IN FVC, FEV1, FEV1/FVC AND PEFR WHICH WAS BETTER AS COMPARED TO CONTROLS. IMPROVEMENT WAS ALSO NOTED IN MEAN-PAQLQ SCORE IN CASES WHICH WAS STATISTICALLY SIGNIFICANTLY BETTER AS COMPARED TO CONTROLS. CONCLUSION: YOGA APPEARS TO HAVE SIGNIFICANT POSITIVE EFFECT ON CONTROL OF ASTHMA MEASURED BY PULMONARY-FUNCTION TEST AND QOL. THEREFORE YOGA THERAPY CAN BE RECOMMENDED AS AN ADJUVANT IN MANAGEMENT OF ASTHMA ALONG WITH STANDARD PHARMACOLOGICAL MANAGEMENT. 2021 6 865 36 EFFECT OF YOGA PRACTICES ON PULMONARY FUNCTION TESTS INCLUDING TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE (TLCO) IN ASTHMA PATIENTS. PRANA IS THE ENERGY, WHEN THE SELF-ENERGIZING FORCE EMBRACES THE BODY WITH EXTENSION AND EXPANSION AND CONTROL, IT IS PRANAYAMA. IT MAY AFFECT THE MILIEU AT THE BRONCHIOLES AND THE ALVEOLI PARTICULARLY AT THE ALVEOLO-CAPILLARY MEMBRANE TO FACILITATE DIFFUSION AND TRANSPORT OF GASES. IT MAY ALSO INCREASE OXYGENATION AT TISSUE LEVEL. AIM OF OUR STUDY IS TO COMPARE PULMONARY FUNCTIONS AND DIFFUSION CAPACITY IN PATIENTS OF BRONCHIAL ASTHMA BEFORE AND AFTER YOGIC INTERVENTION OF 2 MONTHS. SIXTY STABLE ASTHMATIC-PATIENTS WERE RANDOMIZED INTO TWO GROUPS I.E GROUP 1 (YOGA TRAINING GROUP) AND GROUP 2 (CONTROL GROUP). EACH GROUP INCLUDED THIRTY PATIENTS. LUNG FUNCTIONS WERE RECORDED ON ALL PATIENTS AT BASELINE, AND THEN AFTER TWO MONTHS. GROUP 1 SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT (P<0.001) IN TRANSFER FACTOR OF THE LUNG FOR CARBON MONOXIDE (TLCO), FORCED VITAL CAPACITY (FVC), FORCED EXPIRATORY VOLUME IN 1ST SEC (FEV1), PEAK EXPIRATORY FLOW RATE (PEFR), MAXIMUM VOLUNTARY VENTILATION (MVV) AND SLOW VITAL CAPACITY (SVC) AFTER YOGA PRACTICE. QUALITY OF LIFE ALSO INCREASED SIGNIFICANTLY. IT WAS CONCLUDED THAT PRANAYAMA & YOGA BREATHING AND STRETCHING POSTURES ARE USED TO INCREASE RESPIRATORY STAMINA, RELAX THE CHEST MUSCLES, EXPAND THE LUNGS, RAISE ENERGY LEVELS, AND CALM THE BODY. 2012 7 867 47 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 8 2725 41 YOGA NIDRA AS A COMPLEMENTARY TREATMENT OF ANXIETY AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDER. BACKGROUND: EMOTIONAL INSECURITY, STRESS, DEPRESSIVE OR/AND ANXIETY SYMPTOMS ARE COMMON WITH VARIABLE SEVERITY AMONG PATIENTS WITH MENSTRUAL DISORDER. YOGIC RELAXATION THERAPY (YOGA NIDRA) LEADS TO CONSCIOUS AND SUBCONSCIOUS RECOGNITION OF THESE UNDERLYING PSYCHOLOGICAL FACTORS AND HELPS RELEASING OF SUPPRESSED CONFLICTS. OBJECTIVE: TO EVALUATE THE EFFECT OF YOGA NIDRA ON ANXIETY AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDERS. MATERIALS AND METHODS: SUBJECTS WERE RECRUITED FROM THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, C.S.M. MEDICAL UNIVERSITY (ERSTWHILE KGMU), LUCKNOW UTTAR PRADESH, INDIA. THE SUBJECTS WERE RANDOMLY DIVIDED IN TO TWO GROUPS: INTERVENTION GROUP (WITH YOGIC INTERVENTION) AND CONTROL GROUP (WITHOUT YOGIC INTERVENTION). ASSESSMENTS OF ALL SUBJECTS WERE CARRIED OUT BY ADMINISTERING HAMILTON ANXIETY SCALE (HAM-A) AND HAMILTON RATING SCALE FOR DEPRESSION (HAM-D) AT BASELINE AND AFTER SIX MONTHS. RESULTS: THE MEAN AGE WITH S.D OF THE INTERVENTION GROUP WAS 27.67 +/- 7.85 YEARS, AND FOR CONTROL GROUP WAS 26.58 +/- 6.87 YEARS (AMONG COMPLETED INTERVENTION GROUP NN = 65 AND CONTROL GROUP NN = 61). THERE WAS SIGNIFICANT REDUCTION OF SCORES IN HAM-A (P<0.003) AND HAM-D (P<0.02) RESPECTIVELY IN SUBJECTS WITH MILD TO MODERATE ANXIETY AND DEPRESSIVE SYMPTOMS AFTER SIX MONTHS OF YOGA THERAPY (YOGA NIDRA) IN INTERVENTION GROUP IN COMPARISON TO CONTROL GROUP. CONCLUSION: THE PATIENTS WITH MILD TO MODERATE ANXIETY AND DEPRESSIVE SYMPTOMS IMPROVE SIGNIFICANTLY WITH 'YOGA NIDRA' INTERVENTION. THERE IS NO SIGNIFICANT IMPROVEMENT IN THE PATIENTS WITH SEVERE ANXIETY AND DEPRESSIVE SYMPTOMS. 2012 9 1943 46 SAHAJA YOGA IN THE MANAGEMENT OF MODERATE TO SEVERE ASTHMA: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: SAHAJA YOGA IS A TRADITIONAL SYSTEM OF MEDITATION BASED ON YOGIC PRINCIPLES WHICH MAY BE USED FOR THERAPEUTIC PURPOSES. A STUDY WAS UNDERTAKEN TO ASSESS THE EFFECTIVENESS OF THIS THERAPY AS AN ADJUNCTIVE TOOL IN THE MANAGEMENT OF ASTHMA IN ADULT PATIENTS WHO REMAINED SYMPTOMATIC ON MODERATE TO HIGH DOSES OF INHALED STEROIDS. METHODS: A PARALLEL GROUP, DOUBLE BLIND, RANDOMISED CONTROLLED TRIAL WAS CONDUCTED. SUBJECTS WERE RANDOMLY ALLOCATED TO SAHAJA YOGA AND CONTROL INTERVENTION GROUPS. BOTH THE YOGA AND THE CONTROL INTERVENTIONS REQUIRED THE SUBJECTS TO ATTEND A 2 HOUR SESSION ONCE A WEEK FOR 4 MONTHS. ASTHMA RELATED QUALITY OF LIFE (AQLQ, RANGE 0-4), PROFILE OF MOOD STATES (POMS), LEVEL OF AIRWAY HYPERRESPONSIVENESS TO METHACHOLINE (AHR), AND A DIARY CARD BASED COMBINED ASTHMA SCORE (CAS, RANGE 0-12) REFLECTING SYMPTOMS, BRONCHODILATOR USAGE, AND PEAK EXPIRATORY FLOW RATES WERE MEASURED AT THE END OF THE TREATMENT PERIOD AND AGAIN 2 MONTHS LATER. RESULTS: TWENTY ONE OF 30 SUBJECTS RANDOMISED TO THE YOGA INTERVENTION AND 26 OF 29 SUBJECTS RANDOMISED TO THE CONTROL GROUP WERE AVAILABLE FOR ASSESSMENT AT THE END OF TREATMENT. THE IMPROVEMENT IN AHR AT THE END OF TREATMENT WAS 1.5 DOUBLING DOSES (95% CONFIDENCE INTERVAL (CI) 0.0 TO 2.9, P=0.047) GREATER IN THE YOGA INTERVENTION GROUP THAN IN THE CONTROL GROUP. DIFFERENCES IN AQLQ SCORE (0.41, 95% CI -0.04 TO 0.86) AND CAS (0.9, 95% CI -0.9 TO 2.7) WERE NOT SIGNIFICANT (P>0.05). THE AQLQ MOOD SUBSCALE DID IMPROVE MORE IN THE YOGA GROUP THAN IN THE CONTROL GROUP (DIFFERENCE 0.63, 95% CI 0.06 TO 1.20), AS DID THE SUMMARY POMS SCORE (DIFFERENCE 18.4, 95% CI 0.2 TO 36.5, P=0.05). THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN THE TWO GROUPS AT THE 2 MONTH FOLLOW UP ASSESSMENT. CONCLUSIONS: THIS RANDOMISED CONTROLLED TRIAL HAS SHOWN THAT THE PRACTICE OF SAHAJA YOGA DOES HAVE LIMITED BENEFICIAL EFFECTS ON SOME OBJECTIVE AND SUBJECTIVE MEASURES OF THE IMPACT OF ASTHMA. FURTHER WORK IS REQUIRED TO UNDERSTAND THE MECHANISM UNDERLYING THE OBSERVED EFFECTS AND TO ESTABLISH WHETHER ELEMENTS OF THIS INTERVENTION MAY BE CLINICALLY VALUABLE IN PATIENTS WITH SEVERE ASTHMA. 2002 10 1400 43 IMPACT OF YOGA NIDRA ON PSYCHOLOGICAL GENERAL WELLBEING IN PATIENTS WITH MENSTRUAL IRREGULARITIES: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: YOGIC RELAXATION THERAPY (YOGA NIDRA) HAS BEEN EFFECTIVELY PRESCRIBED IN CONJUNCTION WITH OTHER MEDICAL AND YOGIC PROCEDURES IN THE MANAGEMENT OF SEVERE PSYCHOSOMATIC DISEASES, INCLUDING CANCER, BRONCHIAL ASTHMA, COLITIS, PEPTIC ULCER AND MENSTRUAL IRREGULARITIES. AIM OF THE STUDY: TO ASSESS THE IMPACT OF YOGA NIDRA ON PSYCHOLOGICAL PROBLEMS IN PATIENTS WITH MENSTRUAL DISORDERS. MATERIALS AND METHODS: PATIENTS WERE RECRUITED FROM THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, C.S.M. MEDICAL UNIVERSITY (ERSTWHILE KGMU), LUCKNOW, UTTAR PRADESH, INDIA. A TOTAL OF 150 FEMALE SUBJECTS WERE RANDOMLY DIVIDED INTO TWO GROUPS: 1) GROUP OF 75 SUBJECTS (WITH YOGIC INTERVENTION) AND 2) A CONTROL GROUP OF 75 SUBJECTS (WITHOUT YOGIC INTERVENTION). ASSESSMENT OF PSYCHOLOGICAL GENERAL WELLBEING (TOOL) WAS USED FOR ALL THE SUBJECTS ASSESSMENT OF PSYCHOLOGICAL GENERAL WELL BEING (TOOL) WAS USED FOR ALL THE SUBJECTS (CASES AND CONTROLS). THIS ASSESSMENT WAS DONE TWICE FIRST TIME IN THE BEGINNING (BASELINE) AND THEN AFTER SIX MONTHS. RESULTS: ANXIETY DECREASED SIGNIFICANTLY (P<0.003) AND DEPRESSION DECREASED SIGNIFICANTLY (P<0.01) IN THE YOGA GROUP. POSITIVE WELLBEING AND GENERAL HEALTH IMPROVED SIGNIFICANTLY (P<0.02), AND VITALITY IMPROVED SIGNIFICANTLY (P<0.01) AFTER SIX MONTHS OF YOGA THERAPY (YOGA NIDRA) IN THE YOGA GROUP COMPARED WITH THE CONTROL GROUP. CONCLUSION: THE CURRENT FINDINGS SUGGEST THAT PATIENTS WITH MENSTRUAL IRREGULARITIES HAVING PSYCHOLOGICAL PROBLEMS IMPROVED SIGNIFICANTLY IN THE AREAS OF THEIR WELLBEING, ANXIETY AND DEPRESSION BY LEARNING AND APPLYING A PROGRAM BASED ON YOGIC INTERVENTION (YOGA NIDRA). 2011 11 2547 30 YOGA FOR BRONCHIAL ASTHMA: A CONTROLLED STUDY. FIFTY THREE PATIENTS WITH ASTHMA UNDERWENT TRAINING FOR TWO WEEKS IN AN INTEGRATED SET OF YOGA EXERCISES, INCLUDING BREATHING EXERCISES, SURYANAMASKAR, YOGASANA (PHYSICAL POSTURES), PRANAYAMA (BREATH SLOWING TECHNIQUES), DHYANA (MEDITATION), AND A DEVOTIONAL SESSION, AND WERE TOLD TO PRACTISE THESE EXERCISES FOR 65 MINUTES DAILY. THEY WERE THEN COMPARED WITH A CONTROL GROUP OF 53 PATIENTS WITH ASTHMA MATCHED FOR AGE, SEX, AND TYPE AND SEVERITY OF ASTHMA, WHO CONTINUED TO TAKE THEIR USUAL DRUGS. THERE WAS A SIGNIFICANTLY GREATER IMPROVEMENT IN THE GROUP WHO PRACTISED YOGA IN THE WEEKLY NUMBER OF ATTACKS OF ASTHMA, SCORES FOR DRUG TREATMENT, AND PEAK FLOW RATE. THIS STUDY SHOWS THE EFFICACY OF YOGA IN THE LONG TERM MANAGEMENT OF BRONCHIAL ASTHMA, BUT THE PHYSIOLOGICAL BASIS FOR THIS BENEFICIAL EFFECT NEEDS TO BE EXAMINED IN MORE DETAIL. 1985 12 787 36 EFFECT OF YOGA BREATHING EXERCISES (PRANAYAMA) ON AIRWAY REACTIVITY IN SUBJECTS WITH ASTHMA. THE EFFECTS OF TWO PRANAYAMA YOGA BREATHING EXERCISES ON AIRWAY REACTIVITY, AIRWAY CALIBRE, SYMPTOM SCORES, AND MEDICATION USE IN PATIENTS WITH MILD ASTHMA WERE ASSESSED IN A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL. AFTER BASELINE ASSESSMENT OVER 1 WEEK, 18 PATIENTS WITH MILD ASTHMA PRACTISED SLOW DEEP BREATHING FOR 15 MIN TWICE A DAY FOR TWO CONSECUTIVE 2-WEEK PERIODS. DURING THE ACTIVE PERIOD, SUBJECTS WERE ASKED TO BREATHE THROUGH A PINK CITY LUNG (PCL) EXERCISER--A DEVICE WHICH IMPOSES SLOWING OF BREATHING AND A 1:2 INSPIRATION:EXPIRATION DURATION RATIO EQUIVALENT TO PRANAYAMA BREATHING METHODS; DURING THE CONTROL PERIOD, SUBJECTS BREATHED THROUGH A MATCHED PLACEBO DEVICE. MEAN FORCED EXPIRATORY VOLUME IN 1 S (FEV1), PEAK EXPIRATORY FLOW RATE, SYMPTOM SCORE, AND INHALER USE OVER THE LAST 3 DAYS OF EACH TREATMENT PERIOD WERE ASSESSED IN COMPARISON WITH THE BASELINE ASSESSMENT PERIOD; ALL IMPROVED MORE WITH THE PCL EXERCISER THAN WITH THE PLACEBO DEVICE, BUT THE DIFFERENCES WERE NOT SIGNIFICANT. THERE WAS A STATISTICALLY SIGNIFICANT INCREASE IN THE DOSE OF HISTAMINE NEEDED TO PROVOKE A 20% REDUCTION IN FEV1 (PD20) DURING PRANAYAMA BREATHING BUT NOT WITH THE PLACEBO DEVICE. THE USEFULNESS OF CONTROLLED VENTILATION EXERCISES IN THE CONTROL OF ASTHMA SHOULD BE FURTHER INVESTIGATED. 1990 13 660 39 EFFECT OF 12 WEEKS OF YOGA THERAPY ON QUALITY OF LIFE AND INDIAN DIABETES RISK SCORE IN NORMOTENSIVE INDIAN YOUNG ADULT PREDIABETICS AND DIABETICS: RANDOMIZED CONTROL TRIAL. INTRODUCTION: INDIA HAS BECOME THE EPICENTRE FOR DIABETES, A STRESS-RELATED DISORDER AFFECTING THE WORKING SKILLS AND DAY-TO-DAY LIFESTYLE MANAGEMENT OF YOUNGER POPULATION. MOST OF THE STUDIES HAVE REPORTED THE EFFECT OF YOGA ON IMPROVING QUALITY OF LIFE (QOL) IN DIABETIC PATIENTS WITH OTHER COMORBIDITIES. TILL DATE, NO RANDOMIZED CONTROL TRIAL REPORTS ARE AVAILABLE TO SHOW THE EFFECT OF YOGA THERAPY ON QOL AND INDIAN DIABETES RISK SCORE (IDRS) IN NORMOTENSIVE PREDIABETIC AND DIABETIC YOUNG INDIVIDUALS. AIM: TO DETERMINE THE EFFECT OF 12 WEEKS OF YOGA THERAPY ON QOL AND IDRS AMONG NORMOTENSIVE PREDIABETIC AND DIABETIC YOUNG INDIAN ADULTS. MATERIALS AND METHODS: A RANDOMIZED CONTROL TRIAL WAS CONDUCTED IN ENDOCRINOLOGY OUTPATIENT DEPARTMENT (OPD). NORMOTENSIVE PARTICIPANTS (N=310) AGED 18-45 YEARS WERE DIVIDED INTO HEALTHY CONTROLS (N=62), PREDIABETICS (N=124) AND DIABETICS (N=124). STUDY GROUP SUBJECTS WERE RANDOMLY ASSIGNED TO GROUP II (N=62, PREDIABETES-STANDARD TREATMENT), GROUP III (N=62, PREDIABETES-STANDARD TREATMENT + YOGA THERAPY), GROUP IV (N=62, DIABETES-STANDARD TREATMENT) AND GROUP V (N=62, DIABETES-STANDARD TREATMENT + YOGA THERAPY). FLANAGAN QOL SCALE, IDRS QUESTIONNAIRE, FASTING PLASMA GLUCOSE (FPG) AND INSULIN WERE ASSESSED PRE AND POST 12 WEEKS OF INTERVENTION. STATISTICAL ANALYSIS WAS DONE USING STUDENT'S PAIRED T-TEST AND ONE-WAY ANOVA. RESULTS: PRE-POST INTERVENTION ANALYSIS SHOWED SIGNIFICANT IMPROVEMENT IN QOL SCALE WITH P<0.01 IN GROUP II AND GROUP IV; P<0.001 IN GROUP III AND GROUP V RESPECTIVELY. THERE WAS SIGNIFICANT REDUCTION IN IDRS IN GROUP II (P<0.05); P<0.001 IN GROUP III, GROUP IV AND GROUP V RESPECTIVELY. SIGNIFICANT DIFFERENCE (P<0.001) IN QOL SCALE AND IDRS WERE FOUND WHEN STUDY GROUPS WITH STANDARD TREATMENT ALONG WITH YOGA THERAPY WERE COMPARED TO STANDARD TREATMENT ALONE. CONCLUSION: YOGA THERAPY ALONG WITH STANDARD TREATMENT FOR 12 WEEKS IMPROVED QOL AND ATTENUATED THE DIABETES RISK AMONG INDIAN PREDIABETICS AND DIABETICS COMPARED TO STANDARD TREATMENT ALONE. 2017 14 940 45 EFFECTS OF 6 MONTHS YOGA PROGRAM ON RENAL FUNCTIONS AND QUALITY OF LIFE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE. AIM: TO STUDY THE EFFECT OF 6 MONTHS YOGA PROGRAM IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE (CKD). MATERIALS AND METHODS: FIFTY-FOUR PATIENTS WITH CKD WERE STUDIED AND DIVIDED INTO TWO GROUPS (YOGA GROUP AND CONTROL GROUP) TO SEE THE EFFECT OF YOGA IN CKD. PATIENTS IN THE YOGA GROUP WERE OFFERED YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. SUBJECTS IN YOGA GROUP WERE TRAINED TO PERFORM SPECIFIC YOGIC ASANAS FOR AT LEAST 5 DAYS A WEEK FOR 40-60 MIN A DAY. REGULAR MONITORING OF BLOOD PRESSURE, RENAL FUNCTION, REQUIREMENT OF A NUMBER OF DIALYSIS, AND QUALITY OF LIFE (QOL) INDICATORS WERE DONE. FIFTY PATIENTS (YOGA - 25; CONTROL-25) COMPLETED 6 MONTHS FOLLOW-UP. RESULTS: IN YOGA GROUP, A SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, SIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE LEVELS, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF THE WORLD HEALTH ORGANIZATION QOL (AS ASSESSED BY BREF QOL SCORES) WERE SEEN AFTER 6 MONTHS. IN CONTROL GROUP, RISE OF BLOOD PRESSURE, DETERIORATION OF RENAL FUNCTION, AND QOL WERE OBSERVED. POSTSTUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A STATISTICALLY SIGNIFICANT REDUCTION OF BLOOD PRESSURE, NONSIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF QOL IN YOGA GROUP AS COMPARED TO CONTROL GROUP. FOR SUBJECTS IN YOGA GROUP, THE NEED FOR DIALYSIS WAS LESS WHEN COMPARED TO CONTROL GROUP ALTHOUGH THIS DIFFERENCE WAS STATISTICALLY INSIGNIFICANT. EXCEPT FOR INABILITY OF SOME PATIENTS TO PERFORM CERTAIN YOGIC ASANAS NO ADVERSE EFFECT WAS FOUND IN THE STUDY. CONCLUSION: SIX MONTHS YOGA PROGRAM IS SAFE AND EFFECTIVE AS AN ADJUVANT THERAPY IN IMPROVING RENAL FUNCTIONS AND QOL OF CKD PATIENTS. 2017 15 2109 40 THE EFFECT OF YOGA ON RESPIRATORY FUNCTIONS, SYMPTOM CONTROL AND LIFE QUALITY OF ASTHMA PATIENTS: A RANDOMIZED CONTROLLED STUDY. AIM: THIS STUDY WAS CONDUCTED TO FIND OUT THE EFFECT OF YOGA APPLIED TO ASTHMA PATIENTS ON THE PATIENTS' RESPIRATORY FUNCTIONS, SYMPTOM CONTROL AND QUALITY OF LIFE. METHODS: THE SAMPLE OF THE STUDY CONSISTED OF A TOTAL OF RANDOMLY CHOSEN 112 ASTHMA PATIENTS, 56 IN THE EXPERIMENTAL GROUP AND 56 IN THE CONTROL GROUP, WHO MET THE RESEARCH CRITERIA AND WHO AGREED TO PARTICIPATE IN THE STUDY. A TOTAL OF 12 YOGA SESSIONS, 2 SESSIONS A WEEK FOR 6 WEEKS, WAS APPLIED TO THE PATIENTS IN THE EXPERIMENTAL GROUP. THE PATIENTS IN THE CONTROL GROUP DID NOT RECEIVE ANY INTERVENTION. RESULTS: IN THE INTRAGROUP COMPARISON OF AVERAGE PRE-TEST AND POST-TEST SCORES OF RESPIRATORY FUNCTION AND ASTHMA CONTROL TEST (ACT) AND ASTHMA QUALITY OF LIFE SCALE (AQLQ) TOTAL AND SUB-DIMENSION SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP, THE DIFFERENCE WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P<0.05). IN ADDITION, POST-TEST SCORE AVERAGES WERE FOUND TO INCREASE IN THE EXPERIMENTAL GROUP, WHILE THEY WERE FOUND TO DECREASE IN THE CONTROL GROUP. CONCLUSION: IT WAS FOUND THAT YOGA INFLUENCED RESPIRATORY FUNCTIONS, SYMPTOM CONTROL AND QUALITY OF LIFE POSITIVELY IN ASTHMA PATIENTS. THE CLINICAL TRIAL REGISTRATION NUMBER IS NCT04107415/HTTPS://CLINICALTRIALS.GOV/CT2/SHOW/NCT04107415. 2020 16 1087 40 EFFECTS OF YOGA ON SYMPTOM MANAGEMENT IN BREAST CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY ON DISTRESSFUL SYMPTOMS IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. MATERIALS AND METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS DURING THE COURSE OF THEIR ADJUVANT RADIOTHERAPY. ASSESSMENTS INCLUDED ROTTERDAM SYMPTOM CHECK LIST AND EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTC QOL C30) SYMPTOM SCALE. ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: A GLM REPEATED-MEASURES ANOVA SHOWED A SIGNIFICANT DECREASE IN PSYCHOLOGICAL DISTRESS (P = 0.01), FATIGUE (P = 0.007), INSOMNIA (P = 0.001), AND APPETITE LOSS (P = 0.002) OVER TIME IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS SIGNIFICANT IMPROVEMENT IN THE ACTIVITY LEVEL (P = 0.02) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN PHYSICAL AND PSYCHOLOGICAL DISTRESS AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, APPETITE LOSS, AND CONSTIPATION. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN THE ACTIVITY LEVEL AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, AND APPETITE LOSS. CONCLUSION: THE RESULTS SUGGEST BENEFICIAL EFFECTS WITH YOGA INTERVENTION IN MANAGING CANCER-AND TREATMENT-RELATED SYMPTOMS IN BREAST CANCER PATIENTS. 2009 17 1977 41 SIX-MONTH TRIAL OF YOGA NIDRA IN MENSTRUAL DISORDER PATIENTS: EFFECTS ON SOMATOFORM SYMPTOMS. BACKGROUND: YOGA NIDRA IS A SUCCESSFUL THERAPY FOR BOTH RECENT AND LONG-STANDING PSYCHOLOGICAL DISTURBANCES OF ALL KINDS ESPECIALLY DEPRESSION AND HIGH ANXIETY LEVEL AND NEUROTIC PATTERNS. OBJECTIVE: THE PURPOSE OF THE PRESENT WORK, THEREFORE, WAS TO CONDUCT A PRELIMINARY RANDOMIZED STUDY OF YOGA NIDRA AS A TREATMENT IN THE PATIENTS OF MENSTRUAL DISORDERS WITH SOMATOFORM SYMPTOMS. MATERIALS AND METHODS: PATIENTS WERE RECRUITED FROM DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, CSM MEDICAL UNIVERSITY (ERSTWHILE KGMU) LUCKNOW, UTTAR PRADESH, INDIA. ONE HUNDRED AND FIFTY FEMALE PATIENTS WITH MENSTRUAL DISORDERS WERE RANDOMLY DIVIDED IN TO TWO GROUPS 1- INTERVENTION GROUP: 75 SUBJECTS (YOGA NIDRA INTERVENTION AND MEDICATION) 2- CONTROL GROUP: 75 SUBJECTS (WITHOUT YOGA NIDRA INTERVENTION ONLY MEDICATION). SCHEDULE FOR CLINICAL ASSESSMENT IN NEUROPSYCHIATRY TOOL WAS USED. RESULTS: THERE WAS SIGNIFICANT IMPROVEMENT IN PAIN SYMPTOMS (P<0.006), GASTROINTESTINAL SYMPTOMS (P<0.04), CARDIOVASCULAR SYMPTOMS (P<0.02) AND UROGENITAL SYMPTOMS (P<0.005) AFTER 6 MONTHS OF YOGA NIDRA THERAPY IN INTERVENTION GROUP IN COMPARISON TO CONTROL GROUP. CONCLUSION: YOGA NIDRA APPEARS TO BE A PROMISING INTERVENTION FOR PSYCHOSOMATIC PROBLEMS. IT IS COST-EFFECTIVE AND EASY TO IMPLEMENT. THE RESULTS INDICATE THAT SOMATOFORM SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDER CAN BE DECREASED BY LEARNING AND APPLYING A PROGRAM BASED ON YOGIC INTERVENTION (YOGA NIDRA). 2011 18 2197 52 THE EFFICACY OF A COMPREHENSIVE LIFESTYLE MODIFICATION PROGRAMME BASED ON YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THERE IS A SUBSTANTIAL BODY OF EVIDENCE ON THE EFFICACY OF YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA. MANY STUDIES HAVE REPORTED, AS THE EFFECTS OF YOGA ON BRONCHIAL ASTHMA, SIGNIFICANT IMPROVEMENTS IN PULMONARY FUNCTIONS, QUALITY OF LIFE AND REDUCTION IN AIRWAY HYPER-REACTIVITY, FREQUENCY OF ATTACKS AND MEDICATION USE. IN ADDITION, A FEW STUDIES HAVE ATTEMPTED TO UNDERSTAND THE EFFECTS OF YOGA ON EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB) OR EXERCISE TOLERANCE CAPACITY. HOWEVER, NONE OF THESE STUDIES HAS INVESTIGATED ANY IMMUNOLOGICAL MECHANISMS BY WHICH YOGA IMPROVES THESE VARIABLES IN BRONCHIAL ASTHMA. METHODS: THE PRESENT RANDOMIZED CONTROLLED TRIAL (RCT) WAS CONDUCTED ON 57 ADULT SUBJECTS WITH MILD OR MODERATE BRONCHIAL ASTHMA WHO WERE ALLOCATED RANDOMLY TO EITHER THE YOGA (INTERVENTION) GROUP (N = 29) OR THE WAIT-LISTED CONTROL GROUP (N = 28). THE CONTROL GROUP RECEIVED ONLY CONVENTIONAL CARE AND THE YOGA GROUP RECEIVED AN INTERVENTION BASED ON YOGA, IN ADDITION TO THE CONVENTIONAL CARE. THE INTERVENTION CONSISTED OF 2-WK SUPERVISED TRAINING IN LIFESTYLE MODIFICATION AND STRESS MANAGEMENT BASED ON YOGA FOLLOWED BY CLOSELY MONITORED CONTINUATION OF THE PRACTICES AT HOME FOR 6-WK. THE OUTCOME MEASURES WERE ASSESSED IN BOTH THE GROUPS AT 0 WK (BASELINE), 2, 4 AND 8 WK BY USING GENERALIZED LINEAR MODEL (GLM) REPEATED MEASURES FOLLOWED BY POST-HOC ANALYSIS. RESULTS: IN THE YOGA GROUP, THERE WAS A STEADY AND PROGRESSIVE IMPROVEMENT IN PULMONARY FUNCTION, THE CHANGE BEING STATISTICALLY SIGNIFICANT IN CASE OF THE FIRST SECOND OF FORCED EXPIRATORY VOLUME (FEV1) AT 8 WK, AND PEAK EXPIRATORY FLOW RATE (PEFR) AT 2, 4 AND 8 WK AS COMPARED TO THE CORRESPONDING BASELINE VALUES. THERE WAS A SIGNIFICANT REDUCTION IN EIB IN THE YOGA GROUP. HOWEVER, THERE WAS NO CORRESPONDING REDUCTION IN THE URINARY PROSTAGLANDIN D2 METABOLITE (11BETA PROSTAGLANDIN F2ALPHA) LEVELS IN RESPONSE TO THE EXERCISE CHALLENGE. THERE WAS ALSO NO SIGNIFICANT CHANGE IN SERUM EOSINOPHILIC CATIONIC PROTEIN LEVELS DURING THE 8-WK STUDY PERIOD IN EITHER GROUP. THERE WAS A SIGNIFICANT IMPROVEMENT IN ASTHMA QUALITY OF LIFE (AQOL) SCORES IN BOTH GROUPS OVER THE 8-WK STUDY PERIOD. BUT THE IMPROVEMENT WAS ACHIEVED EARLIER AND WAS MORE COMPLETE IN THE YOGA GROUP. THE NUMBER-NEEDED-TO-TREAT WORKED OUT TO BE 1.82 FOR THE TOTAL AQOL SCORE. AN IMPROVEMENT IN TOTAL AQOL SCORE WAS GREATER THAN THE MINIMAL IMPORTANT DIFFERENCE AND THE SAME OUTCOME WAS ACHIEVED FOR THE SUB-DOMAINS OF THE AQOL. THE FREQUENCY OF RESCUE MEDICATION USE SHOWED A SIGNIFICANT DECREASE OVER THE STUDY PERIOD IN BOTH THE GROUPS. HOWEVER, THE DECREASE WAS ACHIEVED RELATIVELY EARLIER AND WAS MORE MARKED IN THE YOGA GROUP THAN IN THE CONTROL GROUP. CONCLUSION: THE PRESENT RCT HAS DEMONSTRATED THAT ADDING THE MIND-BODY APPROACH OF YOGA TO THE PREDOMINANTLY PHYSICAL APPROACH OF CONVENTIONAL CARE RESULTS IN MEASURABLE IMPROVEMENT IN SUBJECTIVE AS WELL AS OBJECTIVE OUTCOMES IN BRONCHIAL ASTHMA. THE TRIAL SUPPORTS THE EFFICACY OF YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA. HOWEVER, THE PRELIMINARY EFFORTS MADE TOWARDS WORKING OUT THE MECHANISM OF ACTION OF THE INTERVENTION HAVE NOT THROWN MUCH LIGHT ON HOW YOGA WORKS IN BRONCHIAL ASTHMA. TRIAL REGISTRATION: CURRENT CONTROLLED TRIALS ISRCTN00815962. 2009 19 190 33 A RANDOMIZED STUDY OF YOGA THERAPY FOR THE PREVENTION OF RECURRENT REFLEX VASOVAGAL SYNCOPE. AIMS: VASOVAGAL SYNCOPE (VVS) IS A COMMON CARDIOVASCULAR DYSAUTONOMIC DISORDER THAT SIGNIFICANTLY IMPACTS HEALTH AND QUALITY OF LIFE (QOL). YOGA HAS BEEN SHOWN TO HAVE A POSITIVE INFLUENCE ON CARDIOVASCULAR AUTONOMICS. THIS STUDY ASSESSED THE EFFECTIVENESS OF YOGA THERAPY ON THE RECURRENCE OF VVS AND QOL. METHODS AND RESULTS: WE RANDOMIZED SUBJECTS WITH RECURRENT REFLEX VVS (>3 EPISODES IN THE PAST 1 YEAR) AND POSITIVE HEAD-UP TILT TEST TO GUIDELINE-DIRECTED THERAPY (GROUP 1) OR YOGA THERAPY (GROUP 2). PATIENTS IN GROUP 1 WERE ADVISED GUIDELINE-DIRECTED TREATMENT AND GROUP 2 WAS TAUGHT YOGA BY A CERTIFIED INSTRUCTOR. THE PRIMARY ENDPOINT WAS VVS RECURRENCES AND QOL. BETWEEN JUNE 2015 AND FEBRUARY 2017, 97 HIGHLY SYMPTOMATIC VVS PATIENTS WERE RANDOMIZED (GROUP 1: 47 AND GROUP 2: 50). THE MEAN AGE WAS 33.1 +/- 16.6 YEARS, MALE:FEMALE OF 40:57, SYMPTOM DURATION OF 17.1 +/- 20.7 MONTHS, WITH A MEAN OF 6.4 +/- 6.1 SYNCOPE EPISODES. OVER A FOLLOW-UP OF 14.3 +/- 2.1 MONTHS GROUP 2 HAD SIGNIFICANTLY LOWER SYNCOPE BURDEN COMPARED WITH GROUP 1 AT 3 (0.8 +/- 0.9 VS. 1.8 +/- 1.4, P < 0.001), 6 (1.0 +/- 1.2 VS. 3.4 +/- 3.0, P < 0.001), AND AT 12 MONTHS (1.1 +/- 0.8 VS. 3.8 +/- 3.2, P < 0.001). THE SYNCOPE FUNCTIONAL SCORE QUESTIONNAIRE WAS SIGNIFICANTLY LOWER IN GROUP 2 COMPARED WITH GROUP 1 AT 3 (31.4 +/- 7.2 VS. 64.1 +/- 11.5, P < 0.001), 6 (26.4 +/- 6.3 VS. 61.4 +/- 10.7, P < 0.001), AND 12 MONTHS (22.2 +/- 4.7 VS. 68.3 +/- 11.4, P < 0.001). CONCLUSION: FOR PATIENTS WITH RECURRENT VVS, GUIDED YOGA THERAPY IS SUPERIOR TO CONVENTIONAL THERAPY IN REDUCING SYMPTOM BURDEN AND IMPROVING QOL. 2021 20 2699 44 YOGA INTERVENTION FOR ADULTS WITH MILD-TO-MODERATE ASTHMA: A PILOT STUDY. BACKGROUND: PRELIMINARY STUDIES INVESTIGATING YOGA AND BREATH WORK FOR TREATING ASTHMA HAVE BEEN PROMISING. SEVERAL RANDOMIZED CONTROLLED TRIALS HAVE SHOWN A BENEFIT FROM YOGA POSTURES AND BREATHING VS CONTROL, BUT THE CONTROL IN THESE CASES INVOLVED NO INTERVENTION OTHER THAN USUAL CARE. THIS STUDY ADVANCES THE FIELD BY PROVIDING AN ACTIVE CONTROL. OBJECTIVE: TO DETERMINE THE EFFECTIVENESS AND FEASIBILITY OF A YOGA AND BREATH WORK INTERVENTION FOR IMPROVING CLINICAL INDICES AND QUALITY OF LIFE IN ADULTS WITH MILD-TO-MODERATE ASTHMA. METHODS: A RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL WAS CONDUCTED BETWEEN OCTOBER 1, 2001, AND MARCH 31, 2003. RANDOM ASSIGNMENT WAS MADE TO EITHER A 4-WEEK YOGA INTERVENTION THAT INCLUDED POSTURES AND BREATH WORK OR A STRETCHING CONTROL CONDITION. OUTCOME MEASURES WERE EVALUATED AT 4, 8, 12, AND 16 WEEKS AND INCLUDED THE MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE, RESCUE INHALER USE, SPIROMETRY, SYMPTOM DIARIES, AND HEALTH CARE UTILIZATION. RESULTS: SIXTY-TWO PARTICIPANTS WERE RANDOMIZED TO THE INTERVENTION AND CONTROL GROUPS, AND 45 COMPLETED THE FINAL FOLLOW-UP MEASURES. INTENTION-TO-TREAT ANALYSIS WAS PERFORMED. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN POSTBRONCHODILATOR FORCED EXPIRATORY VOLUME IN 1 SECOND AND MORNING SYMPTOM SCORES WERE APPARENT IN BOTH GROUPS AT 4 AND 16 WEEKS; HOWEVER, NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED ON ANY OUTCOME MEASURES. CONCLUSIONS: IYENGAR YOGA CONFERRED NO APPRECIABLE BENEFIT IN MILD-TO-MODERATE ASTHMA. CIRCUMSTANCES UNDER WHICH YOGA IS OF BENEFIT IN ASTHMA MANAGEMENT, IF ANY, REMAIN TO BE DETERMINED. 2005